Agranulocytosis due to secondary exposure to antithyroid drugs in a relapsed Graves' disease patient
Year: 2008
Type: article
Study design: Case Report
Abstract: Antithyroid drugs are the most common treatment modality for Graves' disease and are used for the treatment of relapsed Graves' disease in Korea. Agranulocytosis is a rare and severe complication of antithyroid drug therapy, and most cases occur within 3 month after drug treatment. Agranulocytosis can develop in patients who have relapsed Graves' disease and undergo a second course of antithyroid drugs with a prior uneventful course of drug therapy. We report a case of antithyroid drug-induced agranulocytosis in a relapsed Graves' disease patient who had undergone prior uneventful antithyroid drug therapy. We also present a review of the relevant literature.
Authors: Gwi-Hong Jeong, Seong‐Kyun Kim, Dae‐Seong Myung, Jin-Ook Chung, Dong-Hyeok Cho, Dong-Jin Chung, Minyoung Chung
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $500
OpenAlex ID: W2412222815